Global Cell And Gene Therapy Market Size Size, Share, Price, Growth, Key Players, Analysis, Report, Forecast 2023-2031

The ‘Global Cell and Gene Therapy Market Size, Share, Trends, Growth, Analysis, Key Players, Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global cell and gene therapy market, assessing the market on the basis of its segments like therapeutic class, type, product type, end-user, and major regions.

Cell and Gene Therapy Market Size, Trends, Industry Report, Key Player, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2016-2031)

Forecast CAGR (2023-2031): 19.02%

The global cell and gene therapy market is expected to grow at a significant rate during the forecast period. The market growth is attributed to the increasing prevalence of chronic diseases such as cancer, genetic disorders, and others, rising investments in research and development, and increasing adoption of advanced technologies in healthcare.

Get a Free Sample Report with Table of Contents- https://www.expertmarketresearch.com/reports/cell-and-gene-therapy-cgt-market/requestsample

North America is expected to dominate the global cell and gene therapy market owing to the presence of a large number of key players in the region, advanced healthcare infrastructure, and increasing government funding for research and development. The Asia Pacific region is expected to grow at the highest rate during the forecast period due to the increasing adoption of advanced technologies in healthcare, rising healthcare expenditure, and the presence of a large patient population.

Europe is expected to hold a significant share of the global cell and gene therapy market due to the presence of a large number of key players in the region and increasing government funding for research and development.

Overall, the global cell and gene therapy market is expected to witness a significant growth rate during the forecast period due to the increasing prevalence of chronic diseases, rising investments in research and development, and increasing adoption of advanced technologies in healthcare.

Cell and Gene Therapy Industry Definition and Major Segments

Cell and gene therapy refers to the use of living cells and genetic material to treat or prevent diseases. This can include the use of stem cells to regenerate damaged tissue, the use of genetically modified cells to attack cancer cells, and the delivery of therapeutic genes to correct genetic disorders. Cell and gene therapy is a rapidly growing field of medicine that holds great promise for the treatment of a wide range of diseases.

Market Breakup by Therapeutic Class

Rare Diseases
Oncology
Haematology
Cardiology
Ophthalmology
Neurology
Others

Market Breakup by Type

Cell Therapy Types
- Autologous Cell Therapy
- Autogenic Cell Therapy
- Ex-vivo Cell Therapy
- In-vivo Cell Therapy
Gene Therapy Types
- Somatic Cell Gene Therapy
- Germline Gene Therapy
- Ex-vivo Gene Therapy
- In-vivo Gene Therapy

Market Breakup by Product Type

Yescarta
Provenge
Luxtura
Kymriah
Imlygic
Gintuit
MACI
Laviv
Gendicine
Oncorine
Neovasculgen
Strimvelis
Invossa
Zolgenesma
Tecartus
Lisocel
Zyntelego
Others

Market Breakup by End User

Hospitals
Ambulatory Surgical Centres
Wound Care Centres
Cancer Care Centres
Others

Market Breakup by Region

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Read Full Report with Table of Contents- https://www.expertmarketresearch.com/reports/cell-and-gene-therapy-cgt-market

Cell and Gene Therapy Market Trends

The growth of the cell and gene therapy market is driven by advances in technology and research, as well as increasing investment in the field. The increasing understanding of genetic disorders and the development of new genetic engineering techniques, such as CRISPR, have led to the development of more targeted and effective therapies.

The use of stem cells in regenerative medicine has the potential to revolutionize the treatment of a wide range of diseases. The growing prevalence of chronic diseases, such as cancer and genetic disorders, is also driving demand for cell and gene therapies. The increasing ageing population, coupled with the high costs of traditional therapies, is also expected to drive the market.

Furthermore, increasing government funding and collaborations between pharmaceutical companies and academic institutions are also driving the growth of the market. The increasing number of clinical trials and FDA approvals for cell and gene therapy products is also expected to drive market growth. However, the high cost of these therapies and the lack of reimbursement options may pose a challenge to market growth.

Key Market Players

The major players in the cell and gene therapy market report are:

Amgen, Inc.
Bluebird Bio, Inc.
Castle Creek Pharmaceutical Holdings
Kite Pharma, Inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Spark Therapeutics, Inc.
Vericel Corporation
Dendreon Pharmaceuticals LLC.
Human Stem Cells Institute
Dendreon Pharmaceuticals LLC.
Kolon Tissuegene Inc.
Organogenesis Holdings Inc.
Renova Therapeutics.
Others

The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.